id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0093-0002,FDA,FDA-2013-N-0093,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Evaluation of the Program for Enhanced Review Transparency and Communication for New Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription Drug User Fee Act,Notice,30 Day Proposed Information Collection,2013-05-08T04:00:00Z,2013,5,2013-05-08T04:00:00Z,,2015-11-19T19:44:10Z,2013-10898,0,0,09000064812c4599
FDA-2013-N-0093-0001,FDA,FDA-2013-N-0093,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription Drug User Fee Act",Notice,60 Day Proposed Information Collection,2013-02-19T05:00:00Z,2013,2,2013-02-19T05:00:00Z,2013-04-23T03:59:59Z,2024-11-07T22:49:06Z,2013-03705,1,0,09000064811fd0b1